Continuous Glucose Monitors (CGMs) Market New Growth Estimates
Global Continuous Glucose Monitors (CGMs) Market is segmented by Application (Diabetes monitoring, athletic performance, preventive health, telemonitoring, home care, hospital care, glucose trend analysis, metabolic studies), Type (Wearable sensors, transmitters, receivers, implantables, patches, Bluetooth CGMs, AI-integrated CGMs, hybrid CGM-insulin systems), and Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
Pricing
Report Overview
Industry Overview
The Continuous Glucose Monitors (CGMs) market is witnessing significant growth and is expected to expand at a CAGR of 19% during the forecast period from 2025 to 2033. This growth is primarily driven by increasing technological advancements, rising consumer demand, and expanding applications across various industries. Businesses are increasingly adopting innovative solutions to improve operational efficiency, enhance customer experiences, and gain a competitive advantage, further fueling market expansion.
Source: HTF Market Intelligence (HTF MI)
Continuous Glucose Monitors (CGMs) are wearable medical devices that provide real-time glucose level monitoring for diabetic patients. Using sensors and transmitters, CGMs offer continuous data, allowing better glycemic control, reducing hypoglycemia risk, and improving quality of life through timely alerts and data sharing with healthcare providers.
The research study Continuous Glucose Monitors (CGMs) Market gives readers information on tactical business choices and strategic planning that affect and stabilize the growth prediction in the Continuous Glucose Monitors (CGMs) market. However, a few disruptive trends will have opposite and significant effects on the distribution among players and the growth of the Continuous Glucose Monitors (CGMs) market. To give further advice on why certain developments in the Continuous Glucose Monitors (CGMs) market would have a significant impact and specifically why these trends can be taken into account when determining the market's trajectory and industry participants' strategic plans.
Key Highlights
• The Continuous Glucose Monitors (CGMs) is growing at a CAGR of 19% during the forecasted period of 2025 to 2033
• Year-on-year growth for the market is 17%.
• Asia-Pacific dominated the market share in 2025
• Based on type, the market is bifurcated into the Wearable sensors, transmitters, receivers, implantables, patches, Bluetooth CGMs, AI-integrated CGMs, hybrid CGM-insulin systems segment, which dominated the market share during the forecasted period
• Based on application, the market is segmented into Application Diabetes monitoring, athletic performance, preventive health, telemonitoring, home care, hospital care, glucose trend analysis, metabolic studies as the fastest-growing segment.
• North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA import/export in terms of K tons, K units, and metric tons will be provided if applicable, based on industry best practices.
Market Dynamics Highlighted
What Growth Drivers are Powering Demand in the Continuous Glucose Monitors (CGMs) Market?
- • Rising diabetes prevalence.
- • Demand for real-time monitoring.
- • Advances in sensor tech.
- • Integration with insulin pumps.
- • Need for remote patient management.
- • Increasing healthcare digitization.
- • Regulatory approvals easing adoption.
- • Patient preference for non-invasive methods.
- • AI-enabled glucose prediction.
- • Cloud-connected monitoring.
- • Integration with smartphone apps.
- • Wearable design improvements.
- • Data sharing with healthcare teams.
- • Remote monitoring services.
- • Use of digital therapeutics.
- • Expansion in emerging markets.
Why does the Continuous Glucose Monitors (CGMs) Market Face Growth Challenges?
Continuous Glucose Monitors (CGMs) Market Segment Highlighted
Segmentation by Type
- • Wearable sensors
- • transmitters
- • receivers
- • implantables
- • patches
- • Bluetooth CGMs
- • AI-integrated CGMs
- • hybrid CGM-insulin systems
Segmentation by Application
- • Diabetes monitoring
- • athletic performance
- • preventive health
- • telemonitoring
- • home care
- • hospital care
- • glucose trend analysis
- • metabolic studies
Key Players
The companies featured in this profile were selected based on insights from primary experts, evaluating their market penetration, product offerings, and geographical reach. By targeting emerging markets, these companies aim to leverage new opportunities, enhance their competitive advantage, and drive revenue growth. This approach not only aligns with their overall business objectives but also positions them to respond effectively to the evolving demands of consumers in these regions. Several key players in the Continuous Glucose Monitors (CGMs) market are strategically focusing on expanding their operations in developing regions to capture a larger market share, particularly as the year-on-year growth rate for the market stands at 17%.
- • Dexcom (USA)
- • Abbott Laboratories (USA)
- • Medtronic (USA)
- • Senseonics (USA)
- • Roche Diabetes Care (Switzerland)
- • Nemaura Medical (UK)
- • Ascensia Diabetes Care (Switzerland)
- • Tandem Diabetes Care (USA)
- • Eversense (USA)
- • LifeScan (USA)
- • Insulet Corporation (USA)
- • Novo Nordisk (Denmark)
- • Eli Lilly (USA)
- • Sanofi (France)
- • Ypsomed (Switzerland)
- • Biolinq (USA)
- • GlucoMen (Switzerland)
- • Glooko (USA)
- • Bayer Diabetes Care (Germany)
- • Johnson & Johnson (USA)
- • Bigfoot Biomedical (USA)
- • Roche (Switzerland)
- • Abbott (USA)
- • Ascensia (Switzerland)
- • Senseonics (USA)
Regional Insight
The Asia-Pacific dominant region currently dominates the market share, fueled by increasing consumption, population growth, and sustained economic progress, which collectively enhance market demand. Conversely, the North America is growing rapidly, driven by significant infrastructure investments, industrial expansion, and rising consumer demand.
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
- • North America and Europe dominate CGM markets with strong healthcare infrastructure. Asia-Pacific fastest growing due to rising diabetes prevalence. Latin America and Middle East emerging. Regional healthcare policies and reimbursement affect adoption. Increasing consumer awareness worldwide. Telehealth integration growing. Local manufacturing varies.
Market Entropy
Merger & Acquisition
- • Mar-2025
Patent Analysis
- • Patents include sensor technologies
Investment and Funding Scenario
- • Investment robust with strong VC interest in medtech startups. Large pharma and device makers invest heavily. Partnerships with tech firms accelerate innovation. M&A consolidates sensor technology providers. Emerging markets attract investment.
Report Infographics
| Report Features | Details |
| Base Year | 2025 |
| Based Year Market Size (2025) | 10.9 Billion |
| Historical Period | 2020 to 2025 |
| CAGR (2025 to 2033) | 19% |
| Forecast Period | 2026 to 2033 |
| Forecasted Period Market Size (2033) | 47.1 Billion |
| Scope of the Report |
By Type, By Application, By Region |
| Companies Covered | Dexcom (USA), Abbott Laboratories (USA), Medtronic (USA), Senseonics (USA), Roche Diabetes Care (Switzerland), Nemaura Medical (UK), Ascensia Diabetes Care (Switzerland), Tandem Diabetes Care (USA), Eversense (USA), LifeScan (USA), Insulet Corporation (USA), Novo Nordisk (Denmark), Eli Lilly (USA), Sanofi (France), Ypsomed (Switzerland), Biolinq (USA), GlucoMen (Switzerland), Glooko (USA), Bayer Diabetes Care (Germany), Johnson & Johnson (USA), Bigfoot Biomedical (USA), Roche (Switzerland), Abbott (USA), Ascensia (Switzerland), Senseonics (USA) |
| Customization Scope | 15% Free Customization
Want to Buy Specific Sections of This Report?
|
| Delivery Format | PDF and Excel through Email |
The Top-Down and Bottom-Up Approaches
The top-down approach begins with a broad theory or hypothesis and breaks it down into specific components for testing. This structured, deductive process involves developing a theory, creating hypotheses, collecting and analyzing data, and drawing conclusions for Continuous Glucose Monitors (CGMs) Market. It is particularly useful when there is substantial theoretical knowledge, but it can be rigid and may overlook new phenomena developing in Continuous Glucose Monitors (CGMs) Industry.
Conversely, the bottom-up approach starts with specific data or observations, from which broader generalizations and theories were developed in Continuous Glucose Monitors (CGMs) Industry. This inductive process involves collecting detailed data, analyzing it for patterns, developing hypotheses, formulating theories, and validating them with additional data identified for Continuous Glucose Monitors (CGMs) Market. While this approach is flexible and encourages the discovery of new phenomena, it can be time-consuming and less structured.
Regulatory Framework
The healthcare sector is overseen by various regulatory bodies that ensure the safety, quality, and efficacy of health services and products. In the United States, the U.S. Department of Health and Human Services (HHS) plays a crucial role in protecting public health and providing essential human services. Within HHS, the Food and Drug Administration (FDA) regulates food, drugs, and medical devices, ensuring they meet safety and efficacy standards. The Centers for Disease Control and Prevention (CDC) focuses on disease control and prevention, conducting research, and providing health information to protect public health.
Research enthusiast focused on transforming data uncovering into actionable insights through data-driven decision-making.